Our data indicate that MCAM is expressed by both BBB-ECs and by a subset of IL-17-expressing effector memory CD4 lymphocytes, and is a potential adhesion molecule for Th17 entry in the CNS of MS patients and that MCAM engagement influences IL-17 and IFNg release or production.